ROSENBERGER BRIAN (VP, Commercial) received a stock award from ZYNERBA PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/9/2023ACC: 0000899243-23-004446
Officer· VP, Commercial
Since Jan 2019
+9.78K
Net shares
Net buyer
$3.1K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
14.93K acquired · 5.14K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+14.93K
Price / share
—
Trade value
—
% of position
6.7%
2/7/2023
223.99K→238.91K
Common Stock
Direct
Shares
−5.14K
Price / share
$0.60
Trade value
$3.07K
% of position
2.2%
2/8/2023
238.91K→233.77K
Total
Net shares
+9.78K
Net value
-$3.07K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/7/2023 | A · Award | +14.93K | — | — | 6.7% | 223.99K | 238.91K |
| Common Stock Direct | 2/8/2023 | F · Tax Withholding | −5.14K | $0.60 | $3.07K | 2.2% | 238.91K | 233.77K |
| Total | +9.78K | -$3.07K | ||||||
Derivative Transactions0
No derivative transactions reported